A method for labeling adenosine 3':5'-cyclic monophosphate in vivo from precursor adenosine followed by quantitative analysis of the labeled nucleotide is described. When the labeling period is short and the specific activity of the ATP pool is determined, the rate of incorporation of radioactivity corresponds to a'determination of adenylate cyclase activity in vivo. In E. coli B the specific activity of adenylate cyclase in vivo varies under different growth conditions. Under all conditions tested, the adenylate cyclase activity in vivo is great enough to account for the pattern of accumulation of cyclic AMP. This is in contrast to previous adenylate cyclase assays in vitro, where the measured enzyme activities were insufficient to account for the amounts of cyclic AMP accumulated.
We have previously reported that Escherichia coli B accumulates substantial amounts of cyclic AMP (cAMP) extracellularly (1) . During typical growth conditions in glucose-minimal medium, the extracellular cAMP concentration increases dramatically at the end of exponential growth. The coincidence of cAMP accumulation and glucose depletion of the medium (1, 2) indicates that cAMP metabolism is influenced by glucose. In our previous study, we explored the possibility that glucose exhaustion derepresses the synthesis of adenylate cyclase. However, measurements of adenylate cyclase activity in extracts of logarithmic or stationary phase cells gave no indication of higher adenylate cyclase activity in stationary or glucose-starved cells than was found in extracts of logarithmic phase cells. These data were, however, complicated by the fact that the measured activities of adenylate cyclase in extracts were insufficient to account for the amounts of cAMP which accumulated.
With the intention of further studying the mode of regulation of adenylate cyclase under conditions where the enzyme activity is maximally expressed, we have devoted our recent attention to studies in intact cells. The present report details a method whereby rates of cAMP formation can be measured in intact cells. We have termed this the "in vivo" assay for adenylate cyclase. Under these conditions, we show that adenylate cyclase activity is sufficiently high to account for the rate of accumulation of the nucleotide Under various growth conditions. Further, we demonstrate that when glucose is depleted from growth medium, the-re is an increase in the adenylate cyclase activity in vivo sufficient to fully account for the increased accumulation of cAMP.
A portion of this work has been published in abstract form (3) .
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METHODS
All growth experiments reported here were done with E. coli B cultured in a minimal salts medium (4) supplemented with the indicated concentrations of glucose. Growth was determined turbidimetrically at 650 nm in a Gilford model 300 spectrophotometer. Concentrations of unlabeled cAMP were determined by the Gilman procedure (5) as previously described (1) . ATP concentrations were measured by the luciferase procedure, with firefly lantern extract (Sigma) by the procedure of Klofat et al. (6) A 10-ml aliquot of E. coli B in salts medium (4) supplemented with glucose was placed in a 50-ml beaker and subjected to shaking at 370 in a reciprocating water-bath shaker. Under continuous shaking, an aliquot (0.5 ml) of [3H]adenosine (17.7 Ci/mmol, 1 mCi/ml) was added to the sample. For determination of ATP concentration and specific activity, samples (0.1-ml) were withdrawn into tubes containing 0.05 ml of 2 N HCOOH at 20-sec intervals during the reaction. The balance of the incubation was terminated usually at 1 min by addition of 5 ml of 2 N HCOOH. The acidified samples were frozen and thawed, then centrifuged to remove the cell debris.
Determination of [3H]cAMP. The supernatant solutions (usually about 15 ml), after dilution to 20 ml, were adjusted to pH 1.54-1.6 with HCl. An aliquot (0.01 ml) of [14C]cAMP (52.5 Ci/mol, 10 /Ci/ml) was added, and the sample was applied to a column of Dowex-SO (AG50W-X2, 200-400 mesh), 1.5 X 23 cm, that had been equilibrated with HCl solution (pH 1.54-1.6). All column equilibrations, washings, and elutions were with this same HCl Solution. 10-ml Fractions were collected. Those fractions containing the [14C]cAMP were pooled and lyophilized (see Fig. 1A ). The dried sample was dissolved in 6 ml of 0.05 M Tris HCl buffer (pH 7.5). Aliquots (2.5-ml) of this solution were incubated with 0.05 ml of 0.1 M MgCl2 in the presence or absence of 0.4 mg of 3':5'-cyclic nucleotide phosphodiesterase from beef heart (0.45 units/mg of protein) for 30 min at 300. After this incubation period, about 60 A260 units of unlabeled 5'-AMP was added to each sample. 15 ml of HCl was added, and the solutions were adjusted to pH 1.57 with HCl. These samples were applied to columns (0.9 X 21 cm) with an attached reservoir (3 X 20 cm) containing a 9-ml volume of Dowex-50 (AG50W-X8, 100-200 mesh) equlibrated with HCl. The columns were washed with 175 ml of HCl; then a further fraction of 150 ml was collected. On some occasions, as in Fig. 1 B and C, 3 .5-ml fractions were collected.
Measurement of the Am60 of the second fraction usually indicated that 90-100% of the added 5'-AMP was recovered. Aliquots (3-ml) of the fractions containing 5'-AMP were counted in a scintillation counter, under conditions that detected both 14C and 'H. After correction for recovery of the added 5'-AMP, the difference in the 'H counts between the enzyme-treated and untreated samples was calculated. This difference was assumed to correspond to the amount of labeled cAMP originally in that aliquot. The 14C radioactivity recovered was used to calculate the amount of radioactive cAMP in the total original sample. were similarly treated. ATP concentration was determined by a luciferase method (6) on 0.01-ml aliquots of these samples.
16 o Thin-layer chromatography on polyethyleneimine plates was 0 done by spotting 0.005 ml of ATP (5,umol/ml) and 0.005 ml 2 x of the radioactive samples in each channel (7) . The plates°w ere first run with H20, then with 1 M KH2PO4 (pH 3.4). The ATP spots were made visible under ultraviolet light, then cut out and counted with 10 ml of toluene scintillator. The specific activity of ATP was determined from these counts and the ATP concentrations. The specific activity of ATP was used to convert the expression of cAMP radioactivity into concentration (usually pmol).
RESULTS
Measurement of in vivo cAMP formation
The assay for detection of radioactive cAMP synthesized in short time intervals in intact cells was based on the extraction of acid-soluble compounds from cells followed by chromatographic isolation of a fraction enriched in cAMP. Fig. 1 shows the results of a representative fractionation. The major portion of the tritium-labeled radioactivity was resolved from cAMP in the first column fractionation (panel A). The cAMP fraction was treated as described in Methods and rechromatographed. Fig. 1B shows the behavior of the standard [14C]cAMP. In the absence of phosphodiesterase treatment, the radioactivity was eluted in the first fraction, characteristic of cAMP. After phosphodiesterase treatment, the radioacitity eluted later in the second fraction, characteristic of 5'-AMP. Fig. 1C details the behavior of the 3H-labeled sample recovered from the first column. The sample not treated with phosphodiesterase, while not homogeneous, had a main component that chromatographed mainly in the cAMP region. After treatment with phosphodiesterase, essentially all of this main peak shifted to the region characteristic of 5'-AMP. The radioactivity in the 5'-AMP region that specifically resulted from phosphodiesterase treatment was taken as a measure of the amount of cAMP in the original 3H-labeled extract.
Kinetics of cAMP formation in intact cells
Using the radioactive labeling method described in the preceding section, we determined the time course of labeled cAMP synthesis after a single addition of radioactive adenosine (Fig. 2) . The kinetics are curvilinear for 2-3 min. The departure from linearity after that time probably reflects an equilibration of the radioactivity in the ATP pool with that in the cAMP pool. The specific activity of the ATP pool remains essentially constant (about 45 cpm/pmol) from the period 1 through 5 min. To avoid complications due to nonlinear incorporation, the studies to be described were done with 1-min labeling periods.
In vivo cAMP synthesis as a function of the growth stage By use of the assay just described, the initial rates of cAMP synthesis at different stages of growth and under different growth conditions were determined ( (8) . The procedure described here, while more time consuming, should be more universally applicable on two grounds. The authors measured only radioactivity in cAMP without correction for changes in specific activity of the ATP pool. We incorporate a determination of the ATP specific activity in our calculations. More importantly, the isolation of radioactivity in cAMP reported here is designed to separate very small amounts of radioactive cAMP from a large pool of radioactive contaminants. When we tried a BaSO4 fractionation procedure (9) similar to that used by Kuo and De Renzo for purification of radioactive cAMP formed in short-term studies in E. coli, the cAMP fraction was still considerably contaminated. Therefore, the doublecolumn procedure used here, which takes advantage of the specificity of 3'5'-cyclic nucleotide phosphodiesterase, has a greater resolution potential than the BaSO4 procedure. Our previous attempts to measure adenylate cyclase in vitro (1) were not satisfactory on several grounds. Assays in cell extracts tended to be variable and, at best, were too low to account for the level of cAMP that the cells actually accumulated. The in vivo assay does not suffer from these limitations. Not only are the determinations reproducible, but the specific enzyme activities are always high enough to account for the accumulation pattern. These studies have shown that the enzyme activity varies as a function of growth stage as well as the conditions for growth. This is compatible with the idea that the observed regulation of cAMP levels is due to changes in adenylate cyclase activity.
The observed difference in the in vivo adenylate cyclase activity and the amount of cAMP accumulated points up the presence of an active turnover or degradation mechanism. This may be due, in part, to cAMP phosphodiesterase activity. Our demonstration that a substantial part of the cAMP that accumulates is extracellular (1) and resistant to degradation (unpublished results) provides another parameter by which cAMP levels can fluctuate.
These studies do not provide an explanation for the changes in activity of adenylate cyclase under various growth conditions. Variations in ATP concentration clearly do not explain the changes in enzyme activity. The intracellular ATP concentrations are similar throughout growth in both high and low glucose medium, even though the enzyme activities vary markedly in the two growth media. The ATP concentration in stationary phase does, however, appear to be limiting for maximum enzyme activity (unpublished experiments) and provides some possibility for metabolic control.
The increase in adenylate cyclase activity in the transition from logrithmic to stationary phase might be due to (a) an increase in the amount of enzyme or (b) an inhibition of the enzyme activity by glucose or one of its metabolites. The depletion of glucose in stationary phase might then allow the enzyme to express its full activity.
